Press Releases

Roquette marks a step forward in its commitment to sustainable farming practices by expanding and renaming its plant care activity, now known as Agriscience.

Roquette Launches HORIZONS, a new platform created to help food and nutrition businesses anticipate change, explore possible futures, and transform uncertainty into actionable strategies.

Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC) has been awarded first place in the Excipients/Non-Actives category at the 2025 NIE New Ingredient Awards,

Roquette showcases technical expertise with 14 poster presentations and four speaker sessions to meet the evolving needs of pharmaceutical developers.

Roquette has introduced AMYSTA™ L 123 thermally soluble pea starch, the first innovation in its new AMYSTA™ label-friendly starch range.

The Health & Pharma Solutions facility offers state-of-the-art laboratory and training rooms for customers, as part of Roquette’s new Pharmaceutical Innovation Center in São Paulo, to strengthen Latin America as a collaborative hub for health and pharma solutions.

Showcasing the combined strength of Roquette’s Health & Pharma Solutions’ capabilities in excipients, capsules, APIs, and drug delivery technologies at CPhI 2025.

Roquette Boosts Extensive Cyclodextrins Portfolio with Launch of KLEPTOSE® Crysmeb Methyl-Beta-Cyclodextrin for Oral and Parenteral Formulations.

Announcement of Roquette 2025 H1 results, following the approval of its financial statements by the Board of Directors.

The new ingredients are designed to help food manufacturers meet growing demand for nutritious, affordable, and sustainable proteins.

Roquette announces the appointment of Thierry Fournier, currently the CEO of the Southern Europe, Middle East and Africa Region for Saint-Gobain, as its new CEO, effective July 18, 2025.

Roquette launches two strengthened Business Groups with new leaders to boost agility, global reach and sustainable growth.

This strategic milestone marks a significant step forward in Roquette's ambition to become a leader in support of the global pharma markets.

Beauté by Roquette^® ST 305 has an advanced patent-pending porous structure with unique compaction properties and sensory benefits, making it an ideal alternative to mineral and synthetic powders.

Driven by its Pharmaceutical Activities, Roquette's 2024 Results Demonstrate the Resilience of its Integrated Business Model.